Latest News about KRYS

Recent news which mentions KRYS

< Previous 1 2 3 4 Next >

What Will AbbVie Buy Next?

June 28, 2023

Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter

June 06, 2023

Up 48% in 2023, Is This Biotech Stock a Buy?

June 03, 2023

Unlocking a $750 Million Opportunity: Krystal Biotech's Vyjuvek and its Potent Impact on Dystrophic Epidermolysis Bullosa Treatment

May 22, 2023

Why Shares of Krystal Biotech Are Rising Monday

May 22, 2023

Analyst Expectations for Krystal Biotech's Future

May 22, 2023

FDA Approves First Redosable Gene Therapy, Krystal Biotech's Treatment For Skin Blistering Disorder

May 22, 2023

NVIDIA To Rally Around 22%? Here Are 10 Other Analyst Forecasts For Monday

May 22, 2023

Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023

April 18, 2023

Expert Ratings for Krystal Biotech

February 28, 2023

Dentsply Sirona, Chico's FAS, Kontoor Brands And Other Big Stocks Moving Higher On Tuesday

February 28, 2023

Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023

February 28, 2023

Have A Look At William Blair's Top Biotech Picks For 2023

December 25, 2022

The 7 Hottest Biotech Stocks to Own in 2023 and Beyond

December 18, 2022

Krystal Biotech Epidermolysis Bullosa Study Data Published In New England Journal Of Medicine

December 15, 2022

2 Risky Stocks That Could Soar in 2023

December 06, 2022

Krystal Biotech's Subsidiary Posts Durability Data For Fine Line, Wrinkles

November 17, 2022

SolarEdge To Rally 54%? Plus This Analyst Predicts $1,335 For Mettler-Toledo International

November 08, 2022

Cigna To $335? Plus This Analyst Slashes PT On Six Flags Entertainment By 25%

November 08, 2022

Recap: Krystal Biotech Q3 Earnings

November 07, 2022

2 Growth Stocks That Could Double in the Next Year

September 19, 2022

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022

August 25, 2022

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

August 18, 2022

FDA Accepts Krystal Biotech's Filing For Genetic Skin Disorder Candidate Under Priority Review

August 18, 2022

Krystal Biotech, Inc. (KRYS) Comes Up Short on Second Quarter EPS by 9 Cents. KRYS is trading at $83.08

August 08, 2022

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study

August 02, 2022

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

August 01, 2022

Krystal Biotech Gets FDA Nod For Initial-Stage Lung Infection Study

August 01, 2022

Can This Healthcare Stock Keep Beating the Market?

July 30, 2022

Krystal Biotech Files To Seek Approval For Skin Disease Candidate

June 22, 2022

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.